Home » Topics » Disease categories and therapies » Inflammatory

Inflammatory
RSS

Institut Pasteur de Montevideo and Universidad de la Republica describe new trolox derivatives

March 21, 2018

Lycera patents new Rho-associated protein kinase 1/2 inhibitors

March 19, 2018

New polynucleotides encoding semaphorin-6 synthesized at Kanazawa University

March 8, 2018

Novel NF-kappaB inhibitors synthesized at University College Dublin

March 8, 2018

CYP11A1 expression identifies anaphylaxis risk in children with peanut allergy

March 5, 2018

Bristol-Myers Squibb presents phase Ib data for anti-PD-L1 BMS-936559 in sepsis

March 1, 2018

Accro Bioscience divulges necrosis inhibitors

Feb. 16, 2018

Galecto Biotech discovers galectin inhibitors

Feb. 1, 2018

Blade Therapeutics identifies new calpain inhibitors

Jan. 29, 2018

BI-2545 shows promise for the unmet medical need in IPF treatment

Jan. 12, 2018

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for March 31, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for March 31, 2025
Otsuka submits first BLA to FDA for sibeprenlimab in IgAN
BioWorld
Otsuka Pharmaceutical Development & Commercialization Inc. filed its BLA with the U.S. FDA for sibeprenlimab to treat immunoglobulin A nephropathy (IgAN). The...
Corcept looks to NDA following strong phase III ovarian cancer data
BioWorld
Relacorilant, a cortisol modulator from Corcept Therapeutics Inc., produced new and strong phase III results in treating platinum-resistant ovarian cancer. The...
Marks’ departure intensifies regulatory uncertainty at US FDA
BioWorld
Peter Marks’ March 28 letter giving one week’s notice of his resignation as director of the U.S. FDA’s Center for Biologics Evaluation and Research (CBER) is...